Anixa Biosciences, Inc.

NASDAQ:ANIX

3.62 (USD) • At close November 7, 2024
Bedrijfsnaam Anixa Biosciences, Inc.
Symbool ANIX
Munteenheid USD
Prijs 3.62
Beurswaarde 116,489,786
Dividendpercentage 0%
52-weken bereik 2.15 - 5.13
Industrie Biotechnology
Sector Healthcare
CEO Dr. Amit Kumar Ph.D.
Website https://www.anixa.com

An error occurred while fetching data.

Over Anixa Biosciences, Inc.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian

Vergelijkbare Aandelen

Achilles Therapeutics plc logo

Achilles Therapeutics plc

ACHL

1.045 USD

TELA Bio, Inc. logo

TELA Bio, Inc.

TELA

2.99 USD

CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc.

CTMX

1 USD

Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc.

TCRT

2.02 USD

Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc.

CADL

5.09 USD

Champions Oncology, Inc. logo

Champions Oncology, Inc.

CSBR

4.32 USD

Selecta Biosciences, Inc. logo

Selecta Biosciences, Inc.

SELB

0.881 USD

Immuneering Corporation logo

Immuneering Corporation

IMRX

1.93 USD

Leap Therapeutics, Inc. logo

Leap Therapeutics, Inc.

LPTX

3.47 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)